Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to $11.3 million.

  • SeaStar Medical Holding's Cash from Financing Activities rose 9144.79% to $11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.9 million, marking a year-over-year increase of 4532.23%. This contributed to the annual value of $17.6 million for FY2024, which is 6948.34% up from last year.
  • According to the latest figures from Q3 2025, SeaStar Medical Holding's Cash from Financing Activities is $11.3 million, which was up 9144.79% from $4.0 million recorded in Q2 2025.
  • In the past 5 years, SeaStar Medical Holding's Cash from Financing Activities ranged from a high of $11.3 million in Q3 2025 and a low of -$1.0 million during Q2 2024
  • Moreover, its 3-year median value for Cash from Financing Activities was $4.4 million (2024), whereas its average is $4.5 million.
  • Per our database at Business Quant, SeaStar Medical Holding's Cash from Financing Activities tumbled by 16973.23% in 2024 and then surged by 49498.03% in 2025.
  • SeaStar Medical Holding's Cash from Financing Activities (Quarter) stood at $4.6 million in 2023, then fell by 3.44% to $4.4 million in 2024, then soared by 155.19% to $11.3 million in 2025.
  • Its last three reported values are $11.3 million in Q3 2025, $4.0 million for Q2 2025, and $6.1 million during Q1 2025.